NeuraLight logo — Digitizing Neurology

NeuraLight

Digitizing Neurology

Founded 2021 Israel Israel 40 employees Series A Total: $30.50M Health Care, Health and Wellness

General Information

Company Name NeuraLight
Founded Year 2021
Location Israel Israel +1
Founders / Decision Makers
Team member Team member
Employees 40
Industries Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when NeuraLight moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NeuraLight

NeuraLight, a health care startup founded in 2021 and headquartered in Israel, is making waves with its mission to digitize neurology. The company's slogan "Digitizing Neurology" captures its innovative approach to developing a software-based platform for eye movement analysis. This platform serves as an objective and sensitive tool in the realm of neurodegenerative diseases. One of the standout achievements of NeuraLight is the successful utilization of its platform in several CNS clinical trials. These trials have demonstrated the platform's efficacy in utilizing eye movement analysis to differentiate patients from healthy subjects, stratify different subgroups, and monitor disease progression. With a recent influx of funding, NeuraLight secured a significant $25.00M Series A investment on 24 May 2022. The investors contributing to this round include prominent names such as Breyer Capital, Samsung NEXT, Alumni Ventures Blockchain Fund, Koch Disruptive Ventures, VSC Ventures, Asaf Fybish, David Golan, Castor Ventures, Lily Sarafan, and Chris Mansi. NeuraLight's innovative approach, combined with its compelling success in clinical trials, positions the company as a promising player in the intersection of healthcare and technology. As the company continues to develop its platform and garner support from notable investors, it holds potential to make a significant impact in the field of neurology and neurodegenerative diseases.

Taxonomy: AI-powered, digital health, neurology, clinical development, diagnostics, precision medicine, oculometrics, neurological health, video analysis, Parkinson's Disease, ALS, MS, partnership opportunities, non-invasive testing

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 10
Investor Investor Investor Investor
•••• ••••
24 May 2022
Seed Round •••••• - 28 Oct 2021

NeuraLight Alternatives & Competitors

NeuraLight vs
Motusi
Motusi United States

Bringing the lab to the field. Motusi’s performance analysis platform provides advanced insights - a...

7 employees
Health Care, Health and Wellness
NeuraLight vs

Empowering Minds with Comprehensive Mental Health Services.

4 employees
Health Care, Health and Wellness
NeuraLight vs

Developing products to enhance safety and improve life-quality based on eye movement analysis

8 employees
Health Care
Also compare with: NeuraLight vs EuMotus EuMotus

FAQ About NeuraLight

Digitizing Neurology
NeuraLight was founded in 2021.
NeuraLight is headquartered in Israel.
NeuraLight operates in the following industries: Health Care, Health and Wellness.
NeuraLight has approximately 40 employees.
NeuraLight has completed 2 funding rounds, raising a total of $30.50M. The latest funding stage is Series A.
Top alternatives and competitors to NeuraLight include Motusi, Lansing Institute of Behavioral Medicine, Eye Minders, EuMotus, Precision Sports Technology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeuraLight and Motusi are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NeuraLight and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes